PERCEPTIVE ADVISORS LLC - 31 Oct 2022 Form 4 Insider Report for Quotient Ltd

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Nov 2022, 16:58:41 UTC
Prior SEC filing
13 Oct 2022
Next SEC filing
18 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joseph Edelman - for Perceptive Life Sciences Master Fund Ltd., By: Perceptive Advisors LLC, its investment manager, By: Joseph Edelman, its managing member

Key filing fact

PERCEPTIVE ADVISORS LLC filed Form 4 for Quotient Ltd on 02 Nov 2022.

Key facts

  • This page summarizes PERCEPTIVE ADVISORS LLC's Form 4 filing for Quotient Ltd.
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Nov 2022, 16:58.

Change

  • Previous filing in this sequence was filed on 13 Oct 2022.
  • Current net transaction value: -$660,449.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QTNT transaction

Ordinary Shares, nil par value

Sale

Transaction value
$660,449
Shares
-8,255,607
Change %
-51%
Price
$0.0800
Shares after
7,945,211
Date
31 Oct 2022
Ownership
See Footnote
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

PERCEPTIVE ADVISORS LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.078 to $0.088 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range.

Footnote F2

The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .